Beating HIV and COVID-19 may depend on tweaking vaccine molecules
LA JOLLA—Designing a vaccine starts with finding the right ingredients. Every infectious agent has molecules, called antigens, that the immune
LJI Professor Erica Ollmann Saphire awarded $6.4 million for international efforts to beat COVID-19
LA JOLLA—The National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health, has awarded more
LJI team gets first-ever look at a rare but vital stem cell in humans
LA JOLLA—Neutrophils are the warriors of the immune system. They are always ready to spring to action to help heal
Forty percent of people with coronavirus infections have no symptoms. Might they be the key to ending the pandemic?
New research suggests that some of us may be partially protected due to past encounters with common cold coronaviruses
Why antibodies may not be the key to beating coronavirus
Worries over waning antibodies may be overblown, as growing evidence shows a role for T cells in the coronavirus immune response.
The Coronavirus Is New, but Your Immune System Might Still Recognize It
Common cold viruses can spark response against the coronavirus, San Diego scientists report
Exposure to common cold coronaviruses can teach the immune system to recognize SARS-CoV-2
LA JOLLA—Your immune system’s “memory” T cells keep track of the viruses they have seen before. This immune cell memory
La Jolla Institute for Immunology Receives $1 Million from GHR Foundation in Support of COVID-19 Research
LA JOLLA, CA – La Jolla Institute for Immunology (LJI) has announced a $1 million gift from GHR Foundation, an
